Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
Healthcare & PharmaceuticalCompany Update

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development

September 24, 2026 8:05 AM

Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced progress in its next-generation trispecific programs. The Company is optimizing several trispecific candidates for reliable, scalable manufacturing, an essential step toward future human...

Read more
Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA

September 24, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced the submission of the protocol for a Phase 2a clinical study of CY200, the Company's newest drug candidate from the newly acquired Cy Biopharma Inc. This landmark milestone involved the...

Read more
Leveraging Brazil's Health Networks for Early Lung Cancer Detection
Healthcare & PharmaceuticalCompany Update

Leveraging Brazil's Health Networks for Early Lung Cancer Detection

September 24, 2026 7:29 AM

In Brazil, lung cancer is a leading cause of cancer mortality, with approximately 85% of cases diagnosed at an advanced stage. Much of this diagnostic delay stems from systemic fragmentation: While the country's decentralized Unified Health System, or SUS, has built one of Latin America's largest and most digitally-integrated tuberculosis, or TB, care networks, its oncology landscape remains disconnected from primary healthcare - making...

Read more
VOKA 3D Anatomy & Pathology Expands Language Support to French, Spanish, and Portuguese
Healthcare & PharmaceuticalCompany Update

VOKA 3D Anatomy & Pathology Expands Language Support to French, Spanish, and Portuguese

September 24, 2026 7:10 AM

VOKA has expanded VOKA 3D Anatomy & Pathology with French, Spanish, and Portuguese localization, bringing the platform to six supported languages alongside English, German, and Russian. The app currently includes over 1,100 interactive anatomy and pathology models, including more than 750 pathology models spanning 19 medical specialties. The library continues to grow with new content for medical education and professional learning. The new...

Read more
Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging
Healthcare & PharmaceuticalCompany Update

Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging

September 24, 2026 1:50 AM

Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the lives of people living with rare cancer conditions, today announced the publication of a peer-reviewed article related to Orviglance® in the Journal of Magnetic Resonance Imaging (JMRI), one of the leading peer-reviewed journals in the field of magnetic resonance imaging. The article, titled "Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of...

Read more
DC Healthcare Expands Clinic Network with Four New Openings Across Peninsular Malaysia
Healthcare & PharmaceuticalCompany Update

DC Healthcare Expands Clinic Network with Four New Openings Across Peninsular Malaysia

September 24, 2026 1:00 AM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical aesthetic services provider specialising in non-invasive and minimally invasive procedures, today announced the opening of four new medical aesthetic clinics between July and September 2026, further expanding its clinic network across Johor, Selangor and Penang. Dr Chong Clinic in Muar, Johor Dr Chong Clinic in USJ Taipan, Selangor The expansion began in July 2026 with the...

Read more
Power Couple Dr. Vinson Eugene Allen and Dr. Connie Yu Allen Honored by the Los Angeles Business Journal
Healthcare & PharmaceuticalAwards

Power Couple Dr. Vinson Eugene Allen and Dr. Connie Yu Allen Honored by the Los Angeles Business Journal

September 23, 2026 4:40 PM

Power Couple Dr. Vinson Eugene Allen and his wife Dr. Connie Yu Allen of Dusk to Dawn Urgent Care were recently honored by the Los Angeles Business Journal with separate nominations for the Healthcare Leadership Award and CFO of the Year - recognition that highlights their leadership, influence, and continued commitment to expanding accessible healthcare throughout Southern California. Dusk to Dawn Urgent Care has been a staple in Southern...

Read more
Mending Kids Provides Critical Dental Care to Children and Young Adults With Special Needs
Healthcare & PharmaceuticalPartnerships

Mending Kids Provides Critical Dental Care to Children and Young Adults With Special Needs

September 23, 2026 2:00 PM

Mending Kids provided comprehensive dental care to eight children and young adults with significant special needs during its Hometown Mission on September 19 at MemorialCare Outpatient Surgical Center in Long Beach. It marked the organization's second Hometown Mission providing dental care to patients with special needs in the past 12 months. Sponsored by the CDA Foundation, the mission brought together more than 40 dental and medical...

Read more
Connecting Care: Digital Innovation Advancing Health Equity in Canada
Healthcare & PharmaceuticalCompany Update

Connecting Care: Digital Innovation Advancing Health Equity in Canada

September 23, 2026 1:35 PM

It started with a question. Late one evening in rural Quebec, a woman recently diagnosed with peripheral artery disease sat at her kitchen table, overwhelmed and unsure where to turn. Her doctor had explained the condition, but the words blurred under the weight of fear. She needed answers, clear ones, in her language, without medical jargon or judgment. She opened her laptop and typed a question into a new tool she had heard about through the...

Read more
American Kratom Association Expresses Condolences Following Tragic Deaths of University of Mississippi Students
Healthcare & PharmaceuticalCompany Update

American Kratom Association Expresses Condolences Following Tragic Deaths of University of Mississippi Students

September 23, 2026 1:20 PM

The American Kratom Association extends its deepest condolences to the families, friends, classmates, and the entire University of Mississippi community following the tragic deaths of two Ole Miss students. American Kratom Association logo. / Source: American Kratom Association (AKA) (EZ Newswire) The loss of young lives is devastating, and the AKA joins the university community in mourning these students and supporting their families and loved...

Read more
TRNR Publishes Q2 Shareholder Letter Highlighting Record Revenue, Gross Margins, and Adjusted EBITDA
Healthcare & PharmaceuticalEarnings

TRNR Publishes Q2 Shareholder Letter Highlighting Record Revenue, Gross Margins, and Adjusted EBITDA

September 23, 2026 1:00 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, Ergatta, CLMBR and FORME brands, and pending acquirer of STEPR, today published a shareholder letter providing additional management commentary on its record second quarter 2026 results, increased revenue and Adjusted EBITDA guidance for the third quarter of 2026, and its pending acquisition of STEPR, the...

Read more
MD Diet Tracks Fat, Muscle and Bone Loss During GLP-1 Weight Loss as Semaglutide and Tirzepatide Access Expands in Utah
Healthcare & PharmaceuticalCompany Update

MD Diet Tracks Fat, Muscle and Bone Loss During GLP-1 Weight Loss as Semaglutide and Tirzepatide Access Expands in Utah

September 23, 2026 1:00 PM

As semaglutide and tirzepatide become widely available through online programs and primary-care offices, MD Diet, Weight Loss & Nutrition is drawing a distinction between receiving a GLP-1 prescription and receiving comprehensive medical weight loss care. Some patients receive a prescription with limited follow-up, standardized dosing, and no body-composition monitoring. That leaves key questions unanswered: Is the dose still appropriate? Is the...

Read more
CVS Health Launches National
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health Launches National "Wear Your HeART" Bandage Art Contest

September 23, 2026 11:30 AM

CVS Health® (NYSE:CVS) recently announced the launch of its nationwide "Wear Your HeART" Bandage Art Contest, inviting people across the United States to submit original artwork inspired by the importance of protecting personal, family and community health. The contest offers artists, students, families and community groups an opportunity to turn their creativity into a source of inspiration for millions of Americans. Four Grand Prize winners...

Read more
Veterinary Referral Center of Central Oregon Advances Neurosurgery Capabilities and Expands Specialty Team
Healthcare & PharmaceuticalCompany Update

Veterinary Referral Center of Central Oregon Advances Neurosurgery Capabilities and Expands Specialty Team

September 23, 2026 11:00 AM

The Veterinary Referral Center of Central Oregon (VRCCO) continues to solidify its position as a national destination for advanced animal healthcare after successfully performing a highly intricate brain surgery on a ten-year-old feline, Mars, who traveled thousands of miles for care. Mars' journey for treatment highlights the exact purpose of VRCCO's medical travel program: by providing a structured support system that transforms overwhelming...

Read more
Independent Pharmacy Cooperative Acquires IntegralRx
Healthcare & PharmaceuticalMergers and Acquisitions

Independent Pharmacy Cooperative Acquires IntegralRx

September 23, 2026 10:45 AM

Independent Pharmacy Cooperative (IPC) today announced its acquisition of IntegralRx, bringing together two organizations that share a common commitment to helping independent pharmacies remain competitive, profitable, and positioned for long-term success. For years, IntegralRx has served thousands of independent pharmacies by providing competitive purchasing opportunities, personalized service, and trusted relationships built around the needs...

Read more
BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
Healthcare & PharmaceuticalCompany Update

BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video

September 23, 2026 10:15 AM

BioAdaptives, Inc. (OTCID:BDPT), a developer of science-driven wellness formulations, today highlighted a new Instagram video featuring UFC Hall of Famer and former UFC middleweight champion Michael Bisping, who serves as a paid brand ambassador for the company's Xcellara™ and MyndSystem™ platform. Bisping posted the video on September 19, 2026, shortly before the UFC 331 pre-show. Speaking from the venue, he described MyndMed™ as part of his...

Read more
Medical Care Technologies Inc. (OTCID:MDCE) Begins Internal Review of First Volunteer Image Datasets for Melanoma Scan Beta
Healthcare & PharmaceuticalProduct Announcements

Medical Care Technologies Inc. (OTCID:MDCE) Begins Internal Review of First Volunteer Image Datasets for Melanoma Scan Beta

September 23, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that internal review of its first volunteer-submitted image datasets for MDCE Melanoma Scan Beta is now underway. The update follows the Company's September 16 announcement that it had received those first human volunteer datasets. Receipt was the intake milestone. Review is the analysis milestone. The images are now being evaluated inside the Company's multi-phase testing protocol....

Read more
Dr. Alonso Martin Explains EBOO Treatment and Its Role in Modern Wellness Care
Healthcare & PharmaceuticalCompany Update

Dr. Alonso Martin Explains EBOO Treatment and Its Role in Modern Wellness Care

September 23, 2026 9:00 AM

BODYWELLE, a physician-led longevity and functional medicine practice founded by Alonso Martin, MD, offers EBOO therapy as part of its longevity and wellness programs. The treatment circulates blood outside the body through a medical-grade device that filters it, saturates it with a controlled mixture of oxygen and ozone, exposes it to full-spectrum ultraviolet light, and returns it to circulation. Sessions are performed in an outpatient setting...

Read more
T·TIME Launches Fixed-Rate Cash-Pay Program for Compounded Semaglutide and Tirzepatide
Healthcare & PharmaceuticalProduct Announcements

T·TIME Launches Fixed-Rate Cash-Pay Program for Compounded Semaglutide and Tirzepatide

September 23, 2026 8:30 AM

T·TIME has launched a cash-pay telehealth program for compounded injectable semaglutide and tirzepatide. The program uses a single rate that does not vary based on the dose prescribed by the treating clinician. The rate includes medication, physician review, follow-up visits, 24/7 medical support and next-day cold shipping. There is no separate membership fee. Patients may receive dose adjustments during treatment based on the prescribing...

Read more
Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Healthcare & PharmaceuticalCompany Update

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

September 23, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that the Phase II Clinical Trial of the Company's Novel Broad-Spectrum Antiviral Drug NV-387 as a Treatment for Monkeypox Virus Infection has begun with enrollment of first patients in the Democratic Republic of Congo (DRC). This clinical trial was registered in the Pan African Clinical Trials Registry database (pactr.samrc.ac.za). The unique identification number for this...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?